The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING
Science Signaling · 2023
DOI: 10.1126/scisignal.add0082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2023. Verfasst von Dan Cao und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Genomics, Laboratory of Structural Biology and Drug Di…. Hauptthemen laut MEDLINE: Interferon Type I, Coronavirus Papain-Like Proteases, Membrane Proteins, Immune Evasion. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
The SARS-CoV-2 papain-like protease (PLpro), which has deubiquitinating activity, suppresses the type I interferon (IFN-I) antiviral response. We investigated the mechanism by which PLpro antagonizes cellular antiviral responses. In HEK392T cells, PLpro removed K63-linked polyubiquitin chains from Lys 289 of the stimulator of interferon genes (STING). PLpro-mediated deubiquitination of STING disrupted the STING-IKKε-IRF3 complex that induces the production of IFN-β and IFN-stimulated cytokines and chemokines. In human airway cells infected with SARS-CoV-2, the combined treatment with the STING agonist diABZi and the PLpro inhibitor GRL0617 resulted in the synergistic inhibition of SARS-CoV-2 replication and increased IFN-I responses. The PLpros of seven human coronaviruses (SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-229E, HCoV-HKU1, HCoV-OC43, and HCoV-NL63) and four SARS-CoV-2 variants of concern (α, β, γ, and δ) all bound to STING and suppressed STING-stimulated IFN-I responses in HEK293T cells. These findings reveal how SARS-CoV-2 PLpro inhibits IFN-I signaling through STING deubiquitination and a general mechanism used by seven human coronaviral PLpros to dysregulate STING and to facilitate viral innate immune evasion. We also identified simultaneous pharmacological STING activation and PLpro inhibition as a potentially effective strategy for antiviral therapy against SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Genomics, Laboratory of Structural Biology and Drug Discovery, Laboratory of Ubiquitination and Targeted Therapy, School of…
- National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen 518112, PR China.
- Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518132, China.
ORCID-Profile: Dan Cao, Bin Huang, Yuxian Xiong, Guoliang Zhang, Hao Huang
Zitieren
APA
Cao, D., Duan, L., Huang, B., Xiong, Y., Zhang, G., & Huang, H. (2023). The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING. Science Signaling. https://doi.org/10.1126/scisignal.add0082
Vancouver
Cao D, Duan L, Huang B, Xiong Y, Zhang G, Huang H. The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING. Science Signaling. 2023. doi:10.1126/scisignal.add0082
BibTeX
@article{Cao2023,
author = {Cao, Dan and Duan, Lian and Huang, Bin and Xiong, Yuxian and Zhang, Guoliang and Huang, Hao},
title = {The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING},
journal = {Science Signaling},
year = {2023},
doi = {10.1126/scisignal.add0082}
}
EUVIMED